Microneedle Patch Manufacturing: Moulding, Filling and Dose Control

Microneedle Patch Manufacturing: Moulding, Filling and Dose Control

Summary

A microneedle patch is moulded, not coated. Why drying sets the price, how dose uniformity is controlled, and what changes when you scale.

Microneedle Patch Manufacturing: Moulding, Filling and Dose Control

A microneedle patch is moulded, not coated. That single difference from a hydrocolloid patch explains most of its cost, its minimum order and why a hand-made sample tells you almost nothing about production.

Buyers arriving from the hydrocolloid side usually assume a microneedle patch is the same product with a fancier surface. It is a different manufacturing route: a mould, a fill, a drying step and a demould, each with its own failure mode.

The four steps

Mould. A tool with an array of cavities defines dart count, length and spacing. The mould is the product's geometry — changing it is a new tool, not a tweak.

Fill. The active solution goes into the cavities. Fill volume per cavity is what sets dose, and it is the hardest thing to hold constant.

Dry. Water leaves, the matrix sets. This is the bottleneck: a formulation that dries slowly holds the line longer and costs more per patch.

Demould and back. The array is lifted out and bonded to backing film. Darts that break here are scrap, not rework.

Why drying sets the price

Two formulations with the same ingredients at the same dose can differ in cost by a wide margin if one needs longer in the dryer. Line time is the cost unit in this category, not material. That is why a supplier asking "how many darts and how much active per patch" is pricing time, not just chemistry.

It also explains a common disappointment: a sample made by hand in small batches can be dried slowly and gently, while a production run cannot. Ask what the production drying window is, and what the yield is at the end of it.

Dose control is a fill problem

Uniformity depends on three things: cavity volume consistency, how evenly the active sits in the solution before filling, and patch weight after drying. A supplier who can only quote an average dose has not described uniformity — and uniformity is what a label claim actually rests on.

What to ask
Why it matters
Dose per patch, with a tolerance
An average without a range cannot support a claim
Dart count, length and base diameter
Defines the mould and the skin interaction
Production drying window
The main driver of unit cost
Yield and reject handling
Broken darts are scrap; ask where they go
Mould life and replacement cost
Amortised tooling shows up in year two

What changes at scale

Three things, in order of surprise. Mould wear changes cavity geometry gradually, so the thousandth patch is not the first. Reject rate rises with dart count, because more darts means more chances of one breaking. And packing becomes a moisture problem: a water-soluble array in a humid pouch degrades faster than the stability test on a different pack suggests.

For how actives behave inside the matrix, see which actives survive manufacture; for whether the format earns its price, see reading the evidence.

Send the dart count, the dose per patch and the pack format and we will quote the moulding and drying schedule behind them, not just a patch price.

Request a quote

Henso Biotech manufactures hydrocolloid and dissolving microneedle patches for private label brands from 1,000 units per size and pack format. ISO 13485:2016 certified (NQA 69136); manufactured in a U.S. FDA-registered facility.